Overview

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

Status:
TERMINATED

Trial end date:
2025-08-07

Target enrollment:

Participant gender:

Summary

Phase II study: Safety and preliminary efficacy of BAT1308 combined with platinum-containing chemotherapy;Phase III study: Confirmatory safety and efficacy study of BAT1308 combined with platinum-containing chemotherapy for first-line treatment of advanced or recurrent mismatch repair protein-deficient (dMMR) endometrial carcinoma

Phase:

PHASE2

Details

Lead Sponsor:

Bio-Thera Solutions

Treatments:

Carboplatin
Paclitaxel